Published in EMBO J on December 02, 2002
The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu Rev Immunol (2007) 3.59
Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action. Mol Cell Biol (2003) 1.67
Crystal structure of MC159 reveals molecular mechanism of DISC assembly and FLIP inhibition. Mol Cell (2005) 1.53
Role of neutrophils in innate immunity: a systems biology-level approach. Wiley Interdiscip Rev Syst Biol Med (2010) 1.37
Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation. Mol Biol Cell (2005) 1.33
Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem J (2005) 1.24
Molecular basis of MAP kinase regulation. Protein Sci (2013) 1.15
ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15. Proc Natl Acad Sci U S A (2007) 1.13
Solution NMR insights into docking interactions involving inactive ERK2. Biochemistry (2011) 1.03
Death pathways triggered by activated Ras in cancer cells. Front Biosci (Landmark Ed) (2011) 1.00
High ERK protein expression levels correlate with shorter survival in triple-negative breast cancer patients. Oncologist (2012) 0.99
Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15. Mol Biol Cell (2006) 0.98
Structure of ERK2 bound to PEA-15 reveals a mechanism for rapid release of activated MAPK. Nat Commun (2013) 0.96
Characterization of an ERK-binding domain in microphthalmia-associated transcription factor and differential inhibition of ERK2-mediated substrate phosphorylation. J Biol Chem (2005) 0.96
Hsp27 silencing coordinately inhibits proliferation and promotes Fas-induced apoptosis by regulating the PEA-15 molecular switch. Cell Death Differ (2011) 0.92
Phosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoter. Small GTPases (2012) 0.89
PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma. Int J Cancer (2012) 0.85
The PYRIN domain in signal transduction. Curr Protein Pept Sci (2007) 0.85
PEA-15 unphosphorylated at both serine 104 and serine 116 inhibits ovarian cancer cell tumorigenicity and progression through blocking β-catenin. Oncogenesis (2012) 0.85
A phospholipase Cγ1-activated pathway regulates transcription in human vascular smooth muscle cells. Cardiovasc Res (2011) 0.85
Heterodimerization of p45-p75 modulates p75 signaling: structural basis and mechanism of action. PLoS Biol (2014) 0.82
Characterization of a MAPK scaffolding protein logic gate in gonadotropes. Mol Endocrinol (2011) 0.82
Phosphoprotein enriched in astrocytes 15 kDa (PEA-15) reprograms growth factor signaling by inhibiting threonine phosphorylation of fibroblast receptor substrate 2alpha. Mol Biol Cell (2009) 0.81
PLD1 participates in BDNF-induced signalling in cortical neurons. Sci Rep (2015) 0.79
Tumor-suppressor NFκB2 p100 interacts with ERK2 and stabilizes PTEN mRNA via inhibition of miR-494. Oncogene (2015) 0.78
P45 forms a complex with FADD and promotes neuronal cell survival following spinal cord injury. PLoS One (2013) 0.76
Phosphoprotein enriched in astrocytes (PEA)-15: a potential therapeutic target in multiple disease states. Pharmacol Ther (2014) 0.76
Development of PEA-15 using a potent non-viral vector for therapeutic application in breast cancer. Cancer Lett (2014) 0.76
Structural and functional characterization of the recombinant death domain from death-associated protein kinase. PLoS One (2013) 0.76
Substantial conformational change mediated by charge-triad residues of the death effector domain in protein-protein interactions. PLoS One (2013) 0.76
On the Quest of Cellular Functions of PEA-15 and the Therapeutic Opportunities. Pharmaceuticals (Basel) (2015) 0.75
NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR (1995) 93.94
Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins (1991) 36.69
Protein structure comparison by alignment of distance matrices. J Mol Biol (1993) 34.74
AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR (1996) 29.55
Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR (1999) 26.99
Death receptors: signaling and modulation. Science (1998) 16.95
The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry (1992) 9.40
Recognition of errors in three-dimensional structures of proteins. Proteins (1993) 9.38
A novel domain within the 55 kd TNF receptor signals cell death. Cell (1993) 5.59
CD95's deadly mission in the immune system. Nature (2000) 5.55
A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat Cell Biol (2000) 5.46
A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu Rev Cell Dev Biol (1996) 4.74
Phosphorylation of the MAP kinase ERK2 promotes its homodimerization and nuclear translocation. Cell (1998) 3.80
A common sense approach to peak picking in two-, three-, and four-dimensional spectra using automatic computer analysis of contour diagrams. 1991. J Magn Reson (2011) 3.69
Docking domains and substrate-specificity determination for MAP kinases. Trends Biochem Sci (2000) 3.67
NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain. Nature (1997) 3.04
Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase. EMBO J (1997) 2.99
Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature (1999) 2.95
PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev Cell (2001) 2.73
The domains of death: evolution of the apoptosis machinery. Trends Biochem Sci (1999) 2.56
Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol Cell (2002) 2.51
Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions. EMBO J (2001) 2.50
Determining the structures of large proteins and protein complexes by NMR. Trends Biotechnol (1998) 2.49
Evaluation of comparative protein structure modeling by MODELLER-3. Proteins (1997) 2.39
Three-dimensional structure of a complex between the death domains of Pelle and Tube. Cell (1999) 2.39
A calculation strategy for the structure determination of symmetric dimers by 1H NMR. Proteins (1993) 2.16
The impact of direct refinement against 13C alpha and 13C beta chemical shifts on protein structure determination by NMR. J Magn Reson B (1995) 1.84
NMR structure and mutagenesis of the FADD (Mort1) death-effector domain. Nature (1998) 1.65
Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J Cell Biol (2000) 1.60
Insights into programmed cell death through structural biology. Cell (2000) 1.53
Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J Neurosci (1999) 1.52
Identification of novel point mutations in ERK2 that selectively disrupt binding to MEK1. J Biol Chem (2002) 1.49
PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene (1999) 1.49
PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J (1998) 1.47
Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J Biol Chem (1993) 1.43
The death effector domain of PEA-15 is involved in its regulation of integrin activation. J Biol Chem (1998) 1.39
Sources of and solutions to problems in the refinement of protein NMR structures against torsion angle potentials of mean force. J Magn Reson (2000) 1.36
The impact of direct refinement against three-bond HN-C alpha H coupling constants on protein structure determination by NMR. J Magn Reson B (1994) 1.30
The solution structure of FADD death domain. Structural basis of death domain interactions of Fas and FADD. J Biol Chem (1999) 1.26
Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol Biol Cell (2000) 1.22
The modular nature of apoptotic signaling proteins. Cell Mol Life Sci (1999) 1.19
Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate. J Neurochem (1995) 1.13
DEDD, a novel death effector domain-containing protein, targeted to the nucleolus. EMBO J (1998) 1.12
Binding of FADD and caspase-8 to molluscum contagiosum virus MC159 v-FLIP is not sufficient for its antiapoptotic function. J Virol (2002) 1.09
The phosphoprotein protein PEA-15 inhibits Fas- but increases TNF-R1-mediated caspase-8 activity and apoptosis. Dev Biol (1999) 1.03
Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them. J Biol Chem (2000) 1.02
Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signaling. J Biol Chem (2001) 0.97
The major astrocytic phosphoprotein PEA-15 is encoded by two mRNAs conserved on their full length in mouse and human. J Biol Chem (1996) 0.96
Death effector domain-containing proteins DEDD and FLAME-3 form nuclear complexes with the TFIIIC102 subunit of human transcription factor IIIC. Cell Death Differ (2002) 0.96
Mutational analysis and NMR studies of the death domain of the tumor necrosis factor receptor-1. J Mol Biol (2000) 0.93
Identification and characterization of DEDD2, a death effector domain-containing protein. J Biol Chem (2001) 0.90
Regulation of Fas-associated death domain interactions by the death effector domain identified by a modified reverse two-hybrid screen. J Biol Chem (2002) 0.87
Uniform 13C/15N-labeling of DNA by tandem repeat amplification. Methods Enzymol (2001) 0.87
Crystallization and preliminary X-ray studies of extracellular signal-regulated kinase-2/MAP kinase with an incorporated His-tag. J Mol Biol (1993) 0.84
Cell migration: integrating signals from front to back. Science (2003) 29.13
Talin binding to integrin beta tails: a final common step in integrin activation. Science (2003) 7.56
Structural basis of integrin activation by talin. Cell (2007) 5.37
The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol (2010) 4.72
Networks and crosstalk: integrin signalling spreads. Nat Cell Biol (2002) 4.66
Structural determinants of integrin recognition by talin. Mol Cell (2003) 4.20
Src kinase activation by direct interaction with the integrin beta cytoplasmic domain. Proc Natl Acad Sci U S A (2003) 4.03
Reconstructing and deconstructing agonist-induced activation of integrin alphaIIbbeta3. Curr Biol (2006) 3.81
Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat Med (2008) 3.67
An alpha4 integrin-paxillin-Arf-GAP complex restricts Rac activation to the leading edge of migrating cells. Nat Cell Biol (2005) 3.44
The phosphotyrosine binding-like domain of talin activates integrins. J Biol Chem (2002) 2.97
KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell cell junctions. J Cell Biol (2007) 2.92
Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc Natl Acad Sci U S A (2003) 2.89
Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J Exp Med (2007) 2.85
The structure of an integrin/talin complex reveals the basis of inside-out signal transduction. EMBO J (2009) 2.76
Receptor tyrosine kinases and TLR/IL1Rs unexpectedly activate myeloid cell PI3kγ, a single convergent point promoting tumor inflammation and progression. Cancer Cell (2011) 2.70
Recreation of the terminal events in physiological integrin activation. J Cell Biol (2010) 2.48
The structure of the integrin alphaIIbbeta3 transmembrane complex explains integrin transmembrane signalling. EMBO J (2009) 2.45
Regulation of integrin activation. Annu Rev Cell Dev Biol (2011) 2.32
RIAM activates integrins by linking talin to ras GTPase membrane-targeting sequences. J Biol Chem (2008) 2.29
Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J Cell Biol (2007) 2.27
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity. J Exp Med (2010) 2.23
Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway. Nat Med (2009) 2.12
Integrin modulation and signaling in leukocyte adhesion and migration. Immunol Rev (2007) 2.10
Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration. Nat Cell Biol (2009) 1.99
The Kindler syndrome protein is regulated by transforming growth factor-beta and involved in integrin-mediated adhesion. J Biol Chem (2003) 1.97
The antithrombotic potential of selective blockade of talin-dependent integrin alpha IIb beta 3 (platelet GPIIb-IIIa) activation. J Clin Invest (2007) 1.95
Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin alphaIIbbeta3. J Cell Biol (2008) 1.93
Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke (2011) 1.91
CD98hc (SLC3A2) mediates integrin signaling. Proc Natl Acad Sci U S A (2004) 1.88
Transmembrane domain helix packing stabilizes integrin alphaIIbbeta3 in the low affinity state. J Biol Chem (2004) 1.84
Ras GTPases: integrins' friends or foes? Nat Rev Mol Cell Biol (2003) 1.81
Structure of the integrin beta3 transmembrane segment in phospholipid bicelles and detergent micelles. Biochemistry (2008) 1.80
Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity. Nat Cell Biol (2009) 1.73
Antithrombotic effects of targeting alphaIIbbeta3 signaling in platelets. Blood (2008) 1.73
Talin1 and Rap1 are critical for osteoclast function. Mol Cell Biol (2012) 1.68
Matrix-specific suppression of integrin activation in shear stress signaling. Mol Biol Cell (2006) 1.67
Specification of the direction of adhesive signaling by the integrin beta cytoplasmic domain. J Biol Chem (2005) 1.65
Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation. Blood (2012) 1.64
The structure of FADD and its mode of interaction with procaspase-8. Mol Cell (2006) 1.61
Spatial restriction of alpha4 integrin phosphorylation regulates lamellipodial stability and alpha4beta1-dependent cell migration. J Cell Biol (2003) 1.58
Protein kinase A governs a RhoA-RhoGDI protrusion-retraction pacemaker in migrating cells. Nat Cell Biol (2011) 1.51
UV-C irradiation disrupts platelet surface disulfide bonds and activates the platelet integrin alphaIIbbeta3. Blood (2008) 1.51
Competition for talin results in trans-dominant inhibition of integrin activation. J Biol Chem (2004) 1.46
The N-terminal SH2 domains of Syk and ZAP-70 mediate phosphotyrosine-independent binding to integrin beta cytoplasmic domains. J Biol Chem (2002) 1.46
Alpha4 integrins and the immune response. Immunol Rev (2002) 1.45
Talin forges the links between integrins and actin. Nat Cell Biol (2003) 1.45
Interactions of platelet integrin alphaIIb and beta3 transmembrane domains in mammalian cell membranes and their role in integrin activation. Blood (2009) 1.41
Beta integrin tyrosine phosphorylation is a conserved mechanism for regulating talin-induced integrin activation. J Biol Chem (2009) 1.40
A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum Mol Genet (2010) 1.39
Small-molecule synergist of the Wnt/beta-catenin signaling pathway. Proc Natl Acad Sci U S A (2007) 1.39
RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration. J Cell Biol (2006) 1.38
Integrin activation. Biochem Soc Trans (2008) 1.36
Structural determinants of integrin binding to the talin rod. J Biol Chem (2009) 1.35
T4 AsiA blocks DNA recognition by remodeling sigma70 region 4. EMBO J (2004) 1.33
Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation. Mol Biol Cell (2005) 1.33
Integrin-mediated protein kinase A activation at the leading edge of migrating cells. Mol Biol Cell (2008) 1.32
Structural basis for phosphatidylinositol phosphate kinase type Igamma binding to talin at focal adhesions. J Biol Chem (2004) 1.32
Microfluidic devices for studies of shear-dependent platelet adhesion. Lab Chip (2008) 1.32
Rap1 and its effector KRIT1/CCM1 regulate beta-catenin signaling. Dis Model Mech (2009) 1.31
Alpha4 integrins are type I cAMP-dependent protein kinase-anchoring proteins. Nat Cell Biol (2007) 1.31
Integrin alpha4beta1 promotes focal adhesion kinase-independent cell motility via alpha4 cytoplasmic domain-specific activation of c-Src. Mol Cell Biol (2005) 1.30
PEA-15 binding to ERK1/2 MAPKs is required for its modulation of integrin activation. J Biol Chem (2003) 1.30
Basic amino-acid side chains regulate transmembrane integrin signalling. Nature (2011) 1.30
RSK2 activity is regulated by its interaction with PEA-15. J Biol Chem (2003) 1.29
Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem J (2005) 1.24
CD98 at the crossroads of adaptive immunity and cancer. J Cell Sci (2012) 1.24
The talin-tail interaction places integrin activation on FERM ground. Trends Biochem Sci (2004) 1.22
The mechanism of kindlin-mediated activation of integrin αIIbβ3. Curr Biol (2013) 1.22
CD98hc (SLC3A2) participates in fibronectin matrix assembly by mediating integrin signaling. J Cell Biol (2007) 1.21
Domain-specific interactions of talin with the membrane-proximal region of the integrin beta3 subunit. Biochemistry (2003) 1.21
Blocking the alpha 4 integrin-paxillin interaction selectively impairs mononuclear leukocyte recruitment to an inflammatory site. J Clin Invest (2006) 1.20
Talin phosphorylation sites mapped by mass spectrometry. J Cell Sci (2005) 1.19
An easy to assemble microfluidic perfusion device with a magnetic clamp. Lab Chip (2009) 1.18
Alpha4beta1-dependent adhesion strengthening under mechanical strain is regulated by paxillin association with the alpha4-cytoplasmic domain. J Cell Biol (2005) 1.17
Integrin-associated proteins as potential therapeutic targets. Immunol Rev (2008) 1.17
ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15. Proc Natl Acad Sci U S A (2007) 1.13
CD98hc (SLC3A2) interaction with the integrin beta subunit cytoplasmic domain mediates adhesive signaling. J Biol Chem (2007) 1.12
R-Ras regulates migration through an interaction with filamin A in melanoma cells. PLoS One (2010) 1.11
Two modes of integrin activation form a binary molecular switch in adhesion maturation. Mol Biol Cell (2013) 1.10
Integrin alpha 4 beta 1-dependent T cell migration requires both phosphorylation and dephosphorylation of the alpha 4 cytoplasmic domain to regulate the reversible binding of paxillin. J Biol Chem (2003) 1.10
A mechanism of Rap1-induced stabilization of endothelial cell--cell junctions. Mol Biol Cell (2011) 1.09
Talin activates integrins by altering the topology of the β transmembrane domain. J Cell Biol (2012) 1.09
Kindlins, integrin activation and the regulation of talin recruitment to αIIbβ3. PLoS One (2012) 1.08
Structural basis of the junctional anchorage of the cerebral cavernous malformations complex. J Cell Biol (2012) 1.07
Suppression of integrin activation by activated Ras or Raf does not correlate with bulk activation of ERK MAP kinase. Mol Biol Cell (2002) 1.06
Subcellular localization of talin is regulated by inter-domain interactions. J Biol Chem (2012) 1.05
New approaches to blockade of alpha4-integrins, proven therapeutic targets in chronic inflammation. Biochem Pharmacol (2006) 1.05
Reconstruction of integrin activation. Blood (2011) 1.04
PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2. Cancer Res (2007) 1.04
Inhibitors of cell migration that inhibit intracellular paxillin/alpha4 binding: a well-documented use of positional scanning libraries. Chem Biol (2002) 1.04
A fragment of paxillin binds the alpha 4 integrin cytoplasmic domain (tail) and selectively inhibits alpha 4-mediated cell migration. J Biol Chem (2002) 1.03
Bit-1 mediates integrin-dependent cell survival through activation of the NFkappaB pathway. J Biol Chem (2011) 1.03
Tiam1 interaction with the PAR complex promotes talin-mediated Rac1 activation during polarized cell migration. J Cell Biol (2012) 1.01
Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2). J Exp Med (2009) 1.01
RSK isoforms in cancer cell invasion and metastasis. Cancer Res (2013) 1.00